Literature DB >> 31301331

Characterization of a replication-competent vector encoding DsRed based on a human adenovirus type 4 a-like strain.

Xingui Tian1, Yong Chen2, Haitao Li3, Ye Fan2, Zhichao Zhou2, Shiying Chen2, Xiao Li2, Rong Zhou4.   

Abstract

Human adenovirus type 4 (HAdV4) is an etiological agent of acute respiratory disease (ARD) in pediatric and adult patients. HAdV4 strains can be divided into two major genomic clusters, namely prototype (p)-like viruses and a-like viruses. Here, the complete genome sequence of HAdV4 strain GZ01, isolated from a child with ARD in southern China, is first reported and analyzed. This strain was determined to be of the 4a1 genome-type based on in silico restriction profiles. Then, a replication-competent rAd4DsRed virus, containing the HAdV4 GZ01 infectious genome and expressing the reporter molecule DsRed, was generated and characterized. Recombinant rAd4DsRed can infect AD293, hamster, and mouse cells in which DsRed protein was expressed. No changes in antigenicity and genome replication were detected for rAd4DsRed and wild-type HAdV4. Mice immunized with rAd4DsRed was elicited a marked antibody response to DsRed. A rapid method of testing neutralizing antibodies against HAdV3 and HAdV4 was also established using a mixture of rAd4DsRed and rAd3EGFP. Our results provide the foundation to develop HAdV4 vaccines, potential vector platforms for vaccine and gene therapy, and rapid methods for serological and antiviral screening.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  DsRed; Human adenovirus type 4; Neutralizing antibody; Vector

Year:  2019        PMID: 31301331     DOI: 10.1016/j.virusres.2019.197662

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  3 in total

1.  Seroprevalence of Neutralizing Antibodies against Six Human Adenovirus Types Indicates the Low Level of Herd Immunity in Young Children from Guangzhou, China.

Authors:  Xingui Tian; Ye Fan; Changbing Wang; Zhenwei Liu; Wenkuan Liu; Yun Xu; Chuncong Mo; Aiping You; Xiao Li; Xia Rong; Rong Zhou
Journal:  Virol Sin       Date:  2020-11-09       Impact factor: 4.327

2.  Rescue of Recombinant Adenoviruses by CRISPR/Cas-Mediated in vivo Terminal Resolution.

Authors:  André Riedl; Julian Fischer; Hans-Gerhard Burgert; Zsolt Ruzsics
Journal:  Front Microbiol       Date:  2022-03-18       Impact factor: 5.640

3.  Recombinant vesicular stomatitis vaccine against Nipah virus has a favorable safety profile: Model for assessment of live vaccines with neurotropic potential.

Authors:  Thomas P Monath; Richard Nichols; Lynda Tussey; Kelly Scappaticci; Thaddeus G Pullano; Mary D Whiteman; Nikos Vasilakis; Shannan L Rossi; Rafael Kroon Campos; Sasha R Azar; Heidi M Spratt; Brent L Seaton; W Tad Archambault; Yanina V Costecalde; Evan H Moore; Roger J Hawks; Joan Fusco
Journal:  PLoS Pathog       Date:  2022-06-27       Impact factor: 7.464

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.